Skip to content

The application of endoscopic suture technical in refractory non-varicose upper gastrointestinal bleeding

The application of endoscopic suture technical in refractory non-varicose upper gastrointestinal bleeding

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034015
Enrollment
Unknown
Registered
2020-06-21
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory non-varicose upper gastrointestinal bleeding

Interventions

Group 1:endoscopic suture technical
Group 2:medicine treatment

Sponsors

Changshu 1st People's Hospital, Changshu Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
17 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 17 to 75 years old, and there is no serious systemic disease such as heart, lung, liver and kidney, and the coagulation function is normal; 2. The patient does not have any malignant tumor or blood system disease; 3. Complete biochemical and imaging data, as well as relevant data when returning to the gastroenterology clinic every 3 months after recovery and discharge; 4. Preoperative endoscopic confirmation of non-varicose upper gastrointestinal bleeding.

Exclusion criteria

Exclusion criteria: 1. Varicose digestive bleeding or portal hypertension; 2. Long-term oral administration of non-steroidal anti-inflammatory drugs, anti-platelet drugs, anticoagulants and other drugs that may cause gastrointestinal bleeding; 3. Upper gastrointestinal bleeding is within 3 times per year (excluding 3 times) or causes of bleeding are different; 4. Do not agree to sign the informed consent, do not comply with the requirements of this study, or fail to follow up on time or lose follow-up.

Design outcomes

Primary

MeasureTime frame
immediate rate of hemostasis;Long-term recurrence rate;

Secondary

MeasureTime frame
Postoperative hospitalization expenses;Postoperative hospitalization days;Proton pump inhibitor usage during follow-up period;

Countries

China

Contacts

Public ContactXU Xiaodan

Changshu 1st People's Hospital, Changshu Affiliated Hospital of Soochow University

xxd20@163.com+86 18913631835

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026